These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

450 related items for PubMed ID: 15969864

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Meropenem plus amikacin versus piperacillin-tazobactam plus netilmicin as empiric therapy for high-risk febrile neutropenia in children.
    Aksoylar S, Cetingül N, Kantar M, Karapinar D, Kavakli K, Kansoy S.
    Pediatr Hematol Oncol; 2004 Mar; 21(2):115-23. PubMed ID: 15160510
    [Abstract] [Full Text] [Related]

  • 3. Cost efficacy of tazobactam/piperacillin versus imipenem/cilastatin in the treatment of intra-abdominal infection.
    Dietrich ES, Schubert B, Ebner W, Daschner F.
    Pharmacoeconomics; 2001 Jan; 19(1):79-94. PubMed ID: 11252548
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cefepime plus amikacin versus piperacillin-tazobactam plus amikacin for initial antibiotic therapy in haematology patients with febrile neutropenia: results of an open, randomized, multicentre trial.
    Sanz MA, López J, Lahuerta JJ, Rovira M, Batlle M, Pérez C, Vázquez L, Julià A, Palau J, Gutiérrez M, Capote FJ, Ramos F, Benlloch L, Larrea L, Jarque I, Spanish PETHEMA Group.
    J Antimicrob Chemother; 2002 Jul; 50(1):79-88. PubMed ID: 12096010
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Piperacillin-tazobactam vs. imipenem-cilastatin as empirical therapy in hematopoietic stem cell transplantation recipients with febrile neutropenia.
    Jing Y, Li J, Yuan L, Zhao X, Wang Q, Yu L, Zhou D, Huang W.
    Clin Transplant; 2016 Mar; 30(3):263-9. PubMed ID: 26701371
    [Abstract] [Full Text] [Related]

  • 11. Piperacillin/tazobactam: a pharmacoeconomic review of its use in moderate to severe bacterial infections.
    Young M, Plosker GL.
    Pharmacoeconomics; 2001 Mar; 19(11):1135-75. PubMed ID: 11735679
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Monotherapy with piperacillin/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients.
    Hess U, Böhme C, Rey K, Senn HJ.
    Support Care Cancer; 1998 Jul; 6(4):402-9. PubMed ID: 9695210
    [Abstract] [Full Text] [Related]

  • 14. Randomized prospective study comparing cost-effectiveness of teicoplanin and vancomycin as second-line empiric therapy for infection in neutropenic patients.
    Vázquez L, Encinas MP, Morín LS, Vilches P, Gutiérrez N, García-Sanz R, Caballero D, Hurlé AD.
    Haematologica; 1999 Mar; 84(3):231-6. PubMed ID: 10189388
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Comparative study of piperacillin/tazobactam versus imipenem/cilastatin in febrile neutropenia (1994-1996)].
    Figuera A, Rivero N, Pajuelo F, Font P, Leyra F, de La Cámara R, Arranz R, María Fernández Rañada J.
    Med Clin (Barc); 2001 May 05; 116(16):610-1. PubMed ID: 11412645
    [Abstract] [Full Text] [Related]

  • 20. Piperacillin/tazobactam vs imipenem/cilastatin in the treatment of nosocomial pneumonia--a double blind prospective multicentre study.
    Schmitt DV, Leitner E, Welte T, Lode H.
    Infection; 2006 Jun 05; 34(3):127-34. PubMed ID: 16804655
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.